A
andros
Andros is the healthcare industry’s first singular solution that combines rich data and AI to power provider network management
About andros
Andros is a cutting-edge technology company specializing in advanced solutions for the life sciences and healthcare sectors. With a focus on improving clinical trial management and patient care, Andros offers an integrated platform that enhances data collection, patient engagement, and operational efficiency.
Read full description
Their flagship product, Andros, is designed to streamline the complex processes of clinical trials by providing a comprehensive digital ecosystem. This platform supports a range of functionalities including real-time data capture, patient recruitment, and remote monitoring, ensuring a more efficient and effective trial management process. By leveraging innovative technology, Andros aims to reduce the administrative burden on researchers and improve the overall quality of clinical research.
In addition to its core offerings, Andros is committed to advancing the field of healthcare through continuous innovation. The company’s solutions are built with a user-centric approach, prioritizing ease of use and integration with existing systems to facilitate smoother transitions and minimize disruptions. Their technology supports various aspects of clinical trials and patient management, contributing to more accurate results and better patient outcomes.
Andros also places a strong emphasis on data security and compliance, ensuring that all processes adhere to the highest standards of privacy and regulatory requirements. Their commitment to excellence is reflected in their ongoing efforts to refine and enhance their technology, positioning Andros as a leader in the digital transformation of healthcare and clinical research.
At a glance
- Founded
- 2013
- Headquarters
- New York City, United States
- Sector
- Health
- Power Law
- Colt$25–100M revenue
Latest news
Press, funding announcements and product moves mentioning andros.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Blueprint Health
Primary Venture Partners
Kevin Patrick Mahaffey
Bowery Capital
Series A5 investors entered at this stage
Windham Venture Partners
Newark Venture Partners
Meridian Street Capital
Primary Ventures
Questa Capital Management
Series B and later1 investor entered at this stage
Healthy Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about andros on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See andros on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.